loading
Idexx Laboratories Inc stock is traded at $562.13, with a volume of 138.08K. It is down -0.47% in the last 24 hours and down -0.16% over the past month. Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
See More
Previous Close:
$564.74
Open:
$567.07
24h Volume:
138.08K
Relative Volume:
0.24
Market Cap:
$44.36B
Revenue:
$4.45B
Net Income/Loss:
$1.10B
P/E Ratio:
41.36
EPS:
13.591
Net Cash Flow:
$1.06B
1W Performance:
-0.26%
1M Performance:
-0.16%
6M Performance:
-21.29%
1Y Performance:
+7.64%
1-Day Range:
Value
$560.38
$569.06
1-Week Range:
Value
$547.57
$577.49
52-Week Range:
Value
$506.91
$769.98

Idexx Laboratories Inc Stock (IDXX) Company Profile

Name
Name
Idexx Laboratories Inc
Name
Phone
(207) 556-0300
Name
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Name
Employee
11,000
Name
Twitter
@idexx
Name
Next Earnings Date
2026-05-05
Name
Latest SEC Filings
Name
IDXX's Discussions on Twitter

Compare IDXX vs TMO, DHR, A, WAT

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
IDXX icon
IDXX
Idexx Laboratories Inc
562.32 44.23B 4.45B 1.10B 1.06B 13.59
TMO icon
TMO
Thermo Fisher Scientific Inc
475.07 176.13B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
185.35 126.04B 24.78B 3.68B 5.29B 5.1743
A icon
A
Agilent Technologies Inc
136.32 38.81B 7.23B 1.41B 1.09B 4.979
WAT icon
WAT
Waters Corp
367.39 37.29B 3.77B 449.25M 240.68M 7.8556

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-15-26 Initiated Citigroup Neutral
Dec-09-25 Initiated Barclays Overweight
Oct-31-25 Upgrade Stifel Hold → Buy
Oct-01-25 Initiated UBS Neutral
Aug-05-25 Reiterated BTIG Research Buy
Jul-01-25 Initiated Jefferies Buy
Dec-02-24 Initiated Leerink Partners Outperform
Jul-25-24 Initiated BTIG Research Buy
Jan-30-24 Downgrade Piper Sandler Overweight → Neutral
Dec-07-23 Initiated Exane BNP Paribas Outperform
Dec-04-23 Upgrade Cleveland Research Neutral → Buy
Aug-02-23 Downgrade Atlantic Equities Overweight → Neutral
Jul-25-22 Downgrade Stifel Buy → Hold
Jul-21-22 Upgrade Goldman Neutral → Buy
Jul-12-22 Initiated Piper Sandler Overweight
May-05-22 Downgrade BofA Securities Buy → Neutral
Feb-08-22 Initiated Atlantic Equities Overweight
Nov-18-21 Initiated Morgan Stanley Overweight
Aug-05-21 Resumed Credit Suisse Outperform
Jul-12-21 Downgrade Guggenheim Buy → Neutral
Feb-17-21 Initiated Barclays Overweight
Sep-09-19 Initiated Goldman Neutral
May-23-19 Initiated Guggenheim Buy
Nov-02-18 Reiterated BofA/Merrill Buy
May-07-18 Reiterated Stifel Buy
Jan-16-18 Initiated Piper Jaffray Overweight
Aug-23-17 Upgrade BofA/Merrill Neutral → Buy
Jul-28-17 Upgrade CL King Neutral → Buy
Feb-03-17 Downgrade Feltl & Co. Hold → Sell
Sep-29-16 Resumed BofA/Merrill Neutral
Aug-16-16 Reiterated Stifel Buy
Aug-03-16 Upgrade Northcoast Sell → Neutral
Jul-20-16 Reiterated Canaccord Genuity Buy
Apr-19-16 Reiterated Canaccord Genuity Buy
Apr-01-16 Initiated CL King Neutral
Mar-21-16 Reiterated Stifel Buy
Feb-04-16 Initiated Credit Suisse Outperform
Oct-29-15 Reiterated Stifel Buy
Aug-28-15 Downgrade Raymond James Outperform → Mkt Perform
Aug-13-15 Reiterated Stifel Buy
Jul-23-15 Reiterated Canaccord Genuity Buy
View All

Idexx Laboratories Inc Stock (IDXX) Latest News

pulisher
Jun 04, 2026

Is Wall Street bullish or bearish on IDEXX Laboratories stock? - MSN

Jun 04, 2026
pulisher
Jun 03, 2026

IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 03, 2026
pulisher
Jun 02, 2026

IDEXX (IDXX) EVP Fennell reports RSU vesting and tax share withholding - Stock Titan

Jun 02, 2026
pulisher
Jun 02, 2026

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jun 02, 2026
pulisher
Jun 01, 2026

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unveiling 25.84% Potential Upside in the Diagnostics Market - DirectorsTalk Interviews

Jun 01, 2026
pulisher
Jun 01, 2026

How Investors May Respond To IDEXX (IDXX) Expanding SDMA and Fecal Dx Integration in Diagnostics - Sahm

Jun 01, 2026
pulisher
May 31, 2026

IDEXX Laboratories Inc stock (US45167R1041): shares steady as investors digest AI strategy and secto - AD HOC NEWS

May 31, 2026
pulisher
May 30, 2026

IDEXX Laboratories touts AI push, inVue Dx momentum at Stifel conference - MSN

May 30, 2026
pulisher
May 30, 2026

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference - Yahoo Finance

May 30, 2026
pulisher
May 28, 2026

A Look at IDEXX Laboratories Inc (IDXX) After 3.1% Gain -- GF Va - GuruFocus

May 28, 2026
pulisher
May 27, 2026

IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile - Insider Monkey

May 27, 2026
pulisher
May 27, 2026

IDEXX Laboratories stock (US45168D1046): solid Q1 update keeps animal health growth story in focus - AD HOC NEWS

May 27, 2026
pulisher
May 27, 2026

IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 27, 2026
pulisher
May 27, 2026

IDEXX Laboratories Expands Fecal Antigen Testing Platform With Tapeworm Detection - Moomoo

May 27, 2026
pulisher
May 27, 2026

IDEXX Laboratories Inc at Stifel Jaws & Paws Conference Transcript - GuruFocus

May 27, 2026
pulisher
May 26, 2026

IDEXX expands fecal testing to detect taeniid tapeworms By Investing.com - Investing.com Nigeria

May 26, 2026
pulisher
May 26, 2026

Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock? - Barchart.com

May 26, 2026
pulisher
May 26, 2026

IDEXX expands fecal testing to detect taeniid tapeworms - Investing.com

May 26, 2026
pulisher
May 26, 2026

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection - Business Wire

May 26, 2026
pulisher
May 26, 2026

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection – Company Announcement - Financial Times

May 26, 2026
pulisher
May 25, 2026

11 Best Medical Technology Stocks to Buy Right Now - Insider Monkey

May 25, 2026
pulisher
May 25, 2026

IDEXX Laboratories stock (US45168D1046): strong Q1 earnings keep diagnostics specialist in focus - AD HOC NEWS

May 25, 2026
pulisher
May 25, 2026

IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Unveiling a 26.78% Potential Upside in the Diagnostics Arena - DirectorsTalk Interviews

May 25, 2026
pulisher
May 23, 2026

IDEXX Laboratories (IDXX) Is Up 5.8% After Embedding SDMA Into Routine Catalyst CLIPs Testing - Sahm

May 23, 2026
pulisher
May 22, 2026

IDEXX Laboratories stock (US45168D1046): institutional selldown and animal health growth story - AD HOC NEWS

May 22, 2026
pulisher
May 20, 2026

Insider sale notice: IDEXX Labs (NASDAQ: IDXX) files Form 144 - Stock Titan

May 20, 2026
pulisher
May 20, 2026

HARVEY INVESTMENT CO LLC's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus

May 20, 2026
pulisher
May 20, 2026

Should IDEXX’s (IDXX) SDMA-Enhanced Catalyst Panels Prompt Action From Long-Term Diagnostics Investors? - Yahoo Finance

May 20, 2026
pulisher
May 20, 2026

IDEXX announces UK availability of cancer Dx panel for early detection of canine lymphoma - MSN

May 20, 2026
pulisher
May 19, 2026

IDEXX Laboratories stock (US45168D1046): Q1 2026 earnings beat, guidance hike and new kidney test in - AD HOC NEWS

May 19, 2026
pulisher
May 19, 2026

IDEXX Laboratories stock (US45168D1046): Q1 2026 earnings beat and updated guidance keep veterinary - AD HOC NEWS

May 19, 2026
pulisher
May 19, 2026

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles - Business Wire

May 19, 2026
pulisher
May 19, 2026

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles – Company Announcement - Financial Times

May 19, 2026
pulisher
May 18, 2026

IDEXX Laboratories Inc (IDXX) Stock Up 3.2% and Still Undervalued -- GF Score: 99/100 - GuruFocus

May 18, 2026
pulisher
May 18, 2026

IDEXX Laboratories stock (US45168D1046): fresh Q1 2026 earnings and guidance put diagnostics special - AD HOC NEWS

May 18, 2026
pulisher
May 18, 2026

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 34% Potential Upside for Investors - DirectorsTalk Interviews

May 18, 2026
pulisher
May 18, 2026

Elyxium Wealth LLC Invests $3.67 Billion in IDEXX Laboratories, Inc. $IDXX - MarketBeat

May 18, 2026
pulisher
May 17, 2026

IDEXX Laboratories, Inc. $IDXX Shares Sold by Thrivent Financial for Lutherans - MarketBeat

May 17, 2026
pulisher
May 16, 2026

Idexx Laboratories Shareholders Approve Governance and Meeting Reforms - The Globe and Mail

May 16, 2026
pulisher
May 16, 2026

IDEXX Laboratories stock (US45167R1041): Diagnostics demand keeps investors focused - AD HOC NEWS

May 16, 2026
pulisher
May 16, 2026

IDXX Technical Analysis & Stock Price Forecast - Intellectia AI

May 16, 2026
pulisher
May 16, 2026

Northwestern Mutual Wealth Management Co. Increases Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

May 16, 2026
pulisher
May 15, 2026

IDEXX Laboratories stock (US45168D1046): Q1 2025 earnings highlight growth in pet diagnostics - AD HOC NEWS

May 15, 2026
pulisher
May 15, 2026

IDEXX (NASDAQ: IDXX) declassifies board, grants 25% special-meeting right - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Capitalizing On Growth Prospects, Irene Chang Britt Acquires IDEXX Laboratories Stock Options Worth $771 - Benzinga

May 15, 2026
pulisher
May 15, 2026

Bruce L Claflin Backs Up Beliefs With A Notable Acquisition Of IDEXX Laboratories Stock Options Worth $77 - Benzinga

May 15, 2026
pulisher
May 15, 2026

In A Strategic Move, Joseph L Hooley Acquires IDEXX Laboratories Stock Options Worth $771: Enhancing Valu - Benzinga

May 15, 2026

Idexx Laboratories Inc Stock (IDXX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
A A
$135.72
price down icon 1.37%
WAT WAT
$369.07
price down icon 1.75%
$218.97
price down icon 1.19%
IQV IQV
$187.72
price up icon 0.16%
$166.61
price down icon 0.52%
Cap:     |  Volume (24h):